Nine things go into BreathiZen®: three botanical actives and six carriers. A list this short is checkable in an evening, which is the entire argument for keeping it short. Here is every one, and where the evidence for each active stops.
Verbascum thapsus is a roadside biennial with an unusually deep paper trail in respiratory herbalism. Its leaves were brewed and decocted for coughs and chest complaints across European, Turkish and Native American traditions independently of one another. Laboratory surveys identify saponins, the phenylethanoid glycoside verbascoside, flavonoids including quercetin, and iridoids such as aucubin, with several showing antioxidant and anti-inflammatory activity in preclinical models. The saponins are the usual explanation offered for its traditional billing as an expectorant, since saponins behave as surfactants.
Where the evidence stops: no placebo-controlled human trial appears to have tested oral mullein for cough, mucus clearance or any respiratory endpoint. The support is documented tradition plus laboratory chemistry. That combination has produced disappointments before when properly tested, and any page calling mullein clinically proven for lungs is describing a study nobody can name.
Sources: Turker & Camper, Journal of Ethnopharmacology 2002 (PubMed 12241986) · Verbascum review, Biology 2021 (PMC8301161)
This is the ingredient with actual airway research attached. At Columbia University, researchers mounted human airway muscle, tightened it chemically and then exposed it to ordinary kitchen ginger. It loosened — and loosened further with each increase in dose. Testing constituents separately identified 6-gingerol, 8-gingerol and 6-shogaol as responsible, while 10-gingerol produced nothing — a useful detail, because it means the effect tracks specific molecules rather than being a vague property of the plant. Later work located the mechanism in inhibition of phosphodiesterase 4D and phospholipase C, and showed the compounds reinforced a conventional beta-agonist instead of competing with it.
Where the evidence stops: all of that happened to isolated tissue in a bath, epithelium stripped, at a concentration the researchers set. Nothing in that resembles swallowing a spray and asking the compound to survive the stomach, cross the gut wall and clear the liver in a useful amount. The same team has published on that shortfall, noting how quickly ingested ginger constituents are metabolised. No clinical trial has shown oral ginger improves breathing in people.
Sources: Townsend et al., Am J Respir Cell Mol Biol 2013;48:157 · Townsend et al., 2014 (PMC3930933)
The obvious move here would be a vitamin C story, and there is a real literature to borrow from: population studies repeatedly link higher dietary vitamin C with modestly better lung function, and the Dutch MORGEN cohort measured roughly 53 mL more FEV1 between its highest and lowest intake groups.
That research is about years of eating fruit and vegetables, not about flavouring quantities of citrus in a spray. The same study found no association between vitamin C intake and most respiratory symptoms — only with lung function readings. Stretching it to cover this ingredient would be dishonest. It is in the bottle because two months of daily use demands something you don't dread swallowing, and a routine nobody keeps up is a routine that never gets evaluated.
Source: Grievink et al., Thorax 1998, MORGEN study (PubMed 9659349)
The clotting effect of ginger is the interaction worth naming out loud: if warfarin or a similar drug is on your list, raise it before your first dose, and while you have someone's attention, ask about your diabetes and blood pressure medicines too. Pregnancy, breastfeeding and under-18s fall outside its intended use. And if a lung condition has already been diagnosed, nothing here displaces your prescription — this bottle opens no airways and substitutes for nothing.
Every citation is linked. If the formula stands up for you, sixty days covers the rest.
Pick Your Bundle